CJC-1295 + Ipamorelin is a dual-peptide research blend containing 5 mg CJC-1295 without DAC (Modified GRF 1-29) and 5 mg Ipamorelin. CJC-1295 without DAC is a GHRH analog, while Ipamorelin is a selective growth hormone secretagogue-receptor agonist.
The combination supports controlled studies of complementary GHRH- and GHS-receptor signaling, receptor cross-talk, pulsatile pathway responses, and downstream endocrine signaling. Experimental designs should distinguish the effects of the blend from those of each component using appropriate controls.
This formulation specifically uses CJC-1295 without DAC. It is chemically distinct from CJC-1295 DAC and has a different molecular formula and molecular weight. Identity and measured purity are batch-specific.
Research use only. Not for human or veterinary use. Not intended for diagnostic, therapeutic, cosmetic, food, drug, or consumption purposes.
| Composition | CJC-1295 (w/o DAC) 5 mg + Ipamorelin 5 mg (10 mg total) |
|---|---|
| CAS Number | CJC-1295 (w/o DAC): 446036-97-1; Ipamorelin: 170851-70-4 |
| Molecular Weight | CJC-1295 (w/o DAC): 3367.95 g/mol; Ipamorelin: 711.87 g/mol |
| Formula | CJC-1295 (w/o DAC): C152H252N44O42; Ipamorelin: C38H49N9O5 |
| Physical State | Lyophilized powder |
| Purity | >99% HPLC |
Be the first to share your experience with this product.
Share your experience
Reviews are checked before they are published. Your email is used only for review administration and is never displayed.
